What is Mira Pharmaceuticals Forward Dividend Yield %?
As of today (2024-06-01), the Forward Annual Dividend Yield of Mira Pharmaceuticals is 0.00%.
As of today (2024-06-01), the Trailing Annual Dividend Yield of Mira Pharmaceuticals is 0.00%.
MIRA's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.92 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Mira Pharmaceuticals's Forward Dividend Yield %
For the Drug Manufacturers - General subindustry, Mira Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mira Pharmaceuticals's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mira Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Mira Pharmaceuticals's Forward Dividend Yield % falls into.
Mira Pharmaceuticals Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Mira Pharmaceuticals (NAS:MIRA) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Mira Pharmaceuticals Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Mira Pharmaceuticals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Mira Pharmaceuticals (Mira Pharmaceuticals) Business Description
Mira Pharmaceuticals Inc is an early pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic THC analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. Its target patient population is also typically presenting with chronic pain. its drug candidate, MIRA1a, if approved by the FDA, maybe a significant advancement in the treatment of neuropsychiatric, inflammatory, and neurologic diseases and disorders. Based on pre-clinical and animal studies conducted by the company, it believes that MIRA1a enhances the therapeutic potential for treating anxiety, cognitive decline and chronic pain.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MIRA has been successfully added to your